60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.390
-0.040 (-2.80%)
Jun 9, 2026, 4:00 PM EDT - Market closed
SXTP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.31 | 1.41 | 0.68 | 0.25 | 0.51 | 6.35 | |
Revenue Growth (YoY) | 63.89% | 106.81% | 168.70% | -50.40% | -91.95% | - |
Cost of Revenue | 0.79 | 0.78 | 0.38 | 0.47 | 0.43 | 0.85 |
Gross Profit | 0.52 | 0.63 | 0.3 | -0.22 | 0.08 | 5.5 |
Selling, General & Admin | 6.48 | 6.28 | 5.03 | 4.24 | 1.3 | 1.12 |
Research & Development | 1.98 | 2.11 | 4.99 | 0.69 | 0.53 | 5.51 |
Total Operating Expenses | 8.46 | 8.39 | 10.01 | 4.93 | 1.83 | 6.63 |
Operating Income | -7.94 | -7.76 | -9.72 | -5.15 | -1.75 | -1.12 |
Interest Expense | -0.01 | -0.01 | -0.01 | -2.29 | -3.99 | -3.17 |
Other Non-Operating Income (Expense) | 0.37 | 0.4 | 1.77 | 3.63 | -0.44 | 0.04 |
Total Non-Operating Income (Expense) | 0.36 | 0.39 | 1.76 | 1.34 | -4.43 | -3.14 |
Pretax Income | -7.58 | -7.37 | -7.96 | -3.81 | -6.18 | -4.26 |
Provision for Income Taxes | 0 | - | - | -0 | -0 | -0 |
Net Income | -7.58 | -7.37 | -7.96 | -3.81 | -6.18 | -4.26 |
Minority Interest in Earnings | 0 | 0 | 0.01 | 0.05 | -0 | 0.01 |
Net Income Attributable to Preferred Dividends | 0.51 | 0.5 | 0.48 | 0.22 | - | - |
Net Income to Common | -8.06 | -7.86 | -8.43 | -3.92 | -6.18 | -4.27 |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 456.65% | 489.64% | 585.62% | -40.72% | - | 6.71% |
EPS (Basic) | -8.97 | -11.73 | -74.17 | -236.72 | -52.20 | -242.40 |
EPS (Diluted) | -8.97 | -11.73 | -74.17 | -236.72 | -52.20 | -242.40 |
Free Cash Flow | -8.16 | -6.99 | -5.75 | -4.6 | -1.01 | -0.65 |
Free Cash Flow Per Share | -8.00 | -10.43 | -50.60 | -277.50 | -36.11 | -23.32 |
Gross Margin | 39.60% | 44.52% | 43.53% | -87.15% | 15.42% | 86.61% |
Operating Margin | -604.05% | -550.61% | -1425.88% | -2032.78% | -342.41% | -17.69% |
Profit Margin | -576.56% | -522.91% | -1167.64% | -1504.02% | -1208.46% | -67.06% |
FCF Margin | -620.61% | -495.99% | -844.19% | -1814.28% | -197.57% | -10.27% |
EBITDA | -7.85 | -7.68 | -9.65 | -4.32 | -0.51 | -0.45 |
EBITDA Margin | -597.06% | -544.73% | -1416.53% | -1702.60% | -99.13% | -7.05% |
EBIT | -7.94 | -7.76 | -9.72 | -5.15 | -1.75 | -1.12 |
EBIT Margin | -604.05% | -550.61% | -1425.88% | -2032.78% | -342.41% | -17.69% |
Effective Tax Rate | -0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.02% |